{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T20:34:37Z","timestamp":1760646877898,"version":"3.37.3"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,8,9]],"date-time":"2018-08-09T00:00:00Z","timestamp":1533772800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["R01 DA037568","R01 DA037568"],"award-info":[{"award-number":["R01 DA037568","R01 DA037568"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Center for Drug Use & HIV Research","award":["P30DA011041"],"award-info":[{"award-number":["P30DA011041"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Subst Abuse Treat Prev Policy"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s13011-018-0165-2","type":"journal-article","created":{"date-parts":[[2018,8,9]],"date-time":"2018-08-09T13:11:09Z","timestamp":1533820269000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Change and variability in drug treatment coverage among people who inject drugs in 90 large metropolitan areas in the USA, 1993\u20132007"],"prefix":"10.1186","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6128-2510","authenticated-orcid":false,"given":"Barbara","family":"Tempalski","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles M.","family":"Cleland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leslie D.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hannah L. F.","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samuel R.","family":"Friedman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,8,9]]},"reference":[{"key":"165_CR1","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1001\/jama.2016.1910","volume":"315","author":"Y Olsen","year":"2016","unstructured":"Olsen Y. The CDC guideline on opioid prescribing rising to the challenge. JAMA. 2016;315:1577\u20139.","journal-title":"JAMA"},{"key":"165_CR2","first-page":"1","volume":"64","author":"LJ Paulozzi","year":"2015","unstructured":"Paulozzi LJ, Strickler GK, Kreiner PW, Koris CM. Controlled substance prescribing patterns--prescription behavior surveillance system, eight states, 2013. MMWR. 2015;64:1\u201314.","journal-title":"MMWR"},{"key":"165_CR3","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.amepre.2015.02.020","volume":"49","author":"B Levy","year":"2015","unstructured":"Levy B, Paulozzi L, Mack KA, Jones CM. Trends in opioid analgesic-prescribing rates by specialty, U.S., 2007\u20132012. Am J Prev Med. 2015;49:409\u201313.","journal-title":"Am J Prev Med"},{"key":"165_CR4","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1056\/NEJMc1505541","volume":"373","author":"TJ Cicero","year":"2015","unstructured":"Cicero TJ, Ellis MS, Harney J. Shifting patterns of prescription opioid and heroin abuse in the United States. New Eng J Med. 2015;373:1789\u201390.","journal-title":"New Eng J Med"},{"key":"165_CR5","doi-asserted-by":"crossref","unstructured":"Florence C, Luo F, Xu L, Zhou C. The economic burden of prescription opioid overdose, abuse and dependence in the United States, 2013. Med Care. 2016;54","DOI":"10.1097\/MLR.0000000000000625"},{"key":"165_CR6","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1056\/NEJMsa1406143","volume":"372","author":"RC Dart","year":"2015","unstructured":"Dart RC, Surratt HL, Cicero TJ, Parrino MW, Severtson SG, Bucher-Bartelson B, Green JL. Trends in opioid analgesic abuse and mortality in the United States. New Eng J Med. 2015;372:241\u20138.","journal-title":"New Eng J Med"},{"key":"165_CR7","first-page":"1445","volume":"65","author":"RA Rudd","year":"2016","unstructured":"Rudd RA, Seth P, David F, Scholl L. Increases in drug and opioid-involved overdose deaths\u2014United States, 2010\u20132015. MMWR. 2016;65:1445\u201352.","journal-title":"MMWR"},{"key":"165_CR8","first-page":"796","volume":"174","author":"JA Gwira Baumblatt","year":"2014","unstructured":"Gwira Baumblatt JA, Wiedeman C, Dunn JR, Schaffner W, Paulozzi LJ, Jones TF. High-risk use by patients prescribed opioids for pain and its role in overdose deaths. JAMA. 2014;174:796\u2013801.","journal-title":"JAMA"},{"key":"165_CR9","volume-title":"Drug-poisoning deaths involving opioid analgesics: United States, 1999-2011. NCHS data brief no 166","author":"LH Chen","year":"2014","unstructured":"Chen LH, Hedegaard H, Warner M. Drug-poisoning deaths involving opioid analgesics: United States, 1999-2011. NCHS data brief no 166. Hyattsville, MD: National Center for Health Statistics; 2014."},{"key":"165_CR10","volume-title":"Drug overdose deaths in the United States, 1999\u20132015. NCHS data brief no 273","author":"H Hedegaard","year":"2017","unstructured":"Hedegaard H, Warner M, Mini\u00f1o AM. Drug overdose deaths in the United States, 1999\u20132015. NCHS data brief no 273. Hyattsville, MD: National Center for Health Statistics; 2017."},{"key":"165_CR11","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1056\/NEJMra1508490","volume":"374","author":"WM Compton","year":"2016","unstructured":"Compton WM, Jones CM, Baldwin GT. Relationship between nonmedical prescription-opioid use and heroin use. New Eng J Med. 2016;374:154\u201363.","journal-title":"New Eng J Med"},{"key":"165_CR12","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.drugalcdep.2015.12.026","volume":"160","author":"RG Carlson","year":"2016","unstructured":"Carlson RG, Nahhas RW, Martins SS, Daniulaityte R. Predictors of transition to heroin use among initially non-opioid dependent illicit pharmaceutical opioid users: a natural history study. Drug Alcohol Depend. 2016;160:127\u201334.","journal-title":"Drug Alcohol Depend"},{"key":"165_CR13","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1080\/02791072.2012.704591","volume":"44","author":"KM Peavy","year":"2012","unstructured":"Peavy KM, Banta-Green CJ, Kingston S, Hanrahan M, Merrill JO, Coffin PO. \u201cHooked on\u201d prescription-type opiates prior to using heroin: results from a survey of syringe exchange clients. J Psychoactive Drugs. 2012;44:259\u201365.","journal-title":"J Psychoactive Drugs"},{"key":"165_CR14","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.drugpo.2013.10.004","volume":"25","author":"SG Mars","year":"2014","unstructured":"Mars SG, Bourgois P, Karandinos G, Montero F, Ciccarone D. \u201cEvery \u2018never\u2019 I ever said came true\u201d: transitions from opioid pills to heroin injecting. Int J Drug Policy. 2014;25:257\u201366.","journal-title":"Int J Drug Policy"},{"key":"165_CR15","doi-asserted-by":"crossref","unstructured":"Cerd\u00e1 M, Gaidus A, Keyes KM, Ponicki W, Martins S, Galea S, Gruenewald P. Prescription opioid poisoning across urban and rural areas: identifying vulnerable groups and geographic areas. Addiction. 2017;112:103\u2013112","DOI":"10.1111\/add.13543"},{"key":"165_CR16","first-page":"CD012021","volume":"9","author":"L Platt","year":"2017","unstructured":"Platt L, Minozzi S, Reed J, Vickerman P, Hagan H, French C, Jordan A, Degenhardt L, Hope V, Hutchinson S, Maher L, Palmateer N, Taylor A, Bruneau J, Hickman M. Needle syringe programmes and opioid substitution therapy for preventing hepatitis C transmission in people who inject drugs. Cochrane Database Syst Rev. 2017;9:CD012021.","journal-title":"Cochrane Database Syst Rev"},{"key":"165_CR17","doi-asserted-by":"publisher","first-page":"e5945","DOI":"10.1136\/bmj.e5945","volume":"345","author":"GJ MacArthur","year":"2012","unstructured":"MacArthur GJ, Minozzi S, Martin N, Vickerman P, Deren S, Bruneau J, Degenhardt L, Hickman M. Opiate substitution treatment and HIV transmission in people who inject drugs: systematic review and meta-analysis. BMJ. 2012;345:e5945.","journal-title":"BMJ"},{"key":"165_CR18","doi-asserted-by":"publisher","first-page":"2878","DOI":"10.1007\/s10461-013-0593-y","volume":"17","author":"AS Abdul-Quader","year":"2013","unstructured":"Abdul-Quader AS, Feelemyer J, Modi S, Stein ES, Briceno A, Semaan S, Horvath T, Kennedy GE, Des Jarlais DC. Effectiveness of structural-level needle\/syringe programs to reduce HCV and HIV infection among people who inject drugs: a systematic review. AIDS Behavior. 2013;17:2878\u201392. Metzger DS, Woody GE, O\u2019Brian CP: Drug treatment as HIV prevention: a research update. J Acquir Immune Defic Syndr 2010, 55:S32\u201336.","journal-title":"AIDS Behavior"},{"key":"165_CR19","volume-title":"Effectiveness of drug dependence treatment in preventing HIV among injecting drug users: evidence for action technical paper and policy brief","author":"World Health Organization","year":"2005","unstructured":"World Health Organization: Effectiveness of drug dependence treatment in preventing HIV among injecting drug users: evidence for action technical paper and policy brief. 2005, Accessed 1 Mar 2010."},{"key":"165_CR20","doi-asserted-by":"publisher","first-page":"Article ID 3463","DOI":"10.1155\/2013\/346372","volume":"2013","author":"DC Des Jarlais","year":"2013","unstructured":"Des Jarlais DC, Pinkerton S, Hagan H, Guardino V, Feelemyer J, Cooper H, Hatzatkis A, Uuskula A. 30 years on selected issues in the prevention of HIV among persons who inject drugs. Adv Prev Med. 2013;2013:Article ID 346372.","journal-title":"Adv Prev Med"},{"key":"165_CR21","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1016\/S0140-6736(10)60232-2","volume":"375","author":"BM Mathers","year":"2010","unstructured":"Mathers BM, Degenhardt L, Ali H, Wiessing L, Hickman M, Mattick RP, Myers B, Ambekar A, Strathdee SA. HIV prevention, treatment, and care services for people who inject drugs: a systematic review of global, regional, and national coverage. Lancet. 2010;375:1014\u201328.","journal-title":"Lancet"},{"key":"165_CR22","first-page":"303","volume-title":"Encyclopedia of substance abuse prevention, treatment, and recovery","author":"DD Simpson","year":"2008","unstructured":"Simpson DD, Flynn PM. Drug abuse treatment outcome studies (DATOS): A national evaluation of treatment effectiveness. In: Fisher G, Roget N, editors. Encyclopedia of substance abuse prevention, treatment, and recovery. Thousand Oaks, CA: Sage Publishing; 2008. p. 303\u20137."},{"key":"165_CR23","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.jsat.2010.05.004","volume":"39","author":"CL Arfken","year":"2010","unstructured":"Arfken CL, Johanson C, di Menza S, Schuster CR. Expanding treatment capacity for opioid dependence with office-based treatment with buprenorphine: national surveys of physicians. J Subst Abus Treat. 2010;39:96\u2013104.","journal-title":"J Subst Abus Treat"},{"key":"165_CR24","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.drugpo.2007.05.002","volume":"18","author":"F Lert","year":"2007","unstructured":"Lert F, Kazatchkine MD. Antiretroviral HIV treatment and care for injecting drug users: an evidence-based overview. Int J Drug Policy. 2007;18:255\u201361.","journal-title":"Int J Drug Policy"},{"key":"165_CR25","first-page":"1","volume":"63","author":"D Broz","year":"2014","unstructured":"Broz D, Wejnert C, Pham HT, DiNenno E, Heffelfinger JD, Cribbin M, Krishna N, Teshale EH, Paz-Bailey G. HIV infection and risk, prevention, and testing behaviors among injecting drug users -- national HIV behavioral surveillance system, 20 U.S. cities, 2009. MMWR. 2014;63:1\u201351.","journal-title":"MMWR"},{"key":"165_CR26","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1111\/j.1360-0443.2010.02905.x","volume":"105","author":"S Uhlmann","year":"2010","unstructured":"Uhlmann S, Milloy MJ, Kerr T, Zhang R, Guillemi S, Marsh D, Hogg RS, Montaner JS, Wood E. Methadone maintenance therapy promotes initiation of antiretroviral therapy among injection drug users. Addiction. 2010;105:907\u201313.","journal-title":"Addiction"},{"issue":"S4","key":"165_CR27","doi-asserted-by":"publisher","first-page":"S178","DOI":"10.1086\/508181","volume":"43","author":"FL Altice","year":"2006","unstructured":"Altice FL, Sullivan LE, Smith-Rohrberg D, Basu S, Stancliff S, Eldred L. The potential role of buprenorphine in the treatment of opioid dependence in HIV-infected individuals and in HIV infection prevention. Clin Infect Dis. 2006;43(S4):S178\u201383.","journal-title":"Clin Infect Dis"},{"key":"165_CR28","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1111\/add.12970","volume":"110","author":"L Lappalainen","year":"2015","unstructured":"Lappalainen L, Nolan S, Dobrer S, Puscas C, Montaner J, Ahamad K, Dong H, Kerr T, Wood E, Milloy MJ. Dose\u2013response relationship between methadone dose and adherence to antiretroviral therapy among HIV-positive people who use illicit opioids. Addiction. 2015;110:1330\u20139.","journal-title":"Addiction"},{"key":"165_CR29","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.drugpo.2006.12.014","volume":"18","author":"B Spire","year":"2007","unstructured":"Spire B, Lucas GM, Carrieri MP. Adherence to HIV treatment among IDUs and the role of opioid substitution treatment (OST). Int J Drug Policy. 2007;18:262\u201370.","journal-title":"Int J Drug Policy"},{"key":"165_CR30","doi-asserted-by":"publisher","first-page":"214","DOI":"10.2307\/2137033","volume":"29","author":"JC Ball","year":"1988","unstructured":"Ball JC, Lange WR, Myers CP, Friedman SR. Reducing the risk of AIDS through methadone maintenance treatment. J Health Soc Behav. 1988;29:214\u201326.","journal-title":"J Health Soc Behav"},{"key":"165_CR31","doi-asserted-by":"publisher","first-page":"4","DOI":"10.2174\/1874473711104010004","volume":"4","author":"D Henkel","year":"2011","unstructured":"Henkel D. Unemployment and substance use: a review of the literature 1990-2010. Curr Drug Abuse Rev. 2011;4:4\u201327.","journal-title":"Curr Drug Abuse Rev"},{"key":"165_CR32","doi-asserted-by":"publisher","first-page":"S5","DOI":"10.1016\/j.drugpo.2014.11.007","volume":"26","author":"DP Wilson","year":"2015","unstructured":"Wilson DP, Donald B, Shattock AJ, Wilson D, Frazer-Hunt N. The cost-effectiveness of harm reduction. Int J Drug Policy. 2015;26:S5\u2013S11.","journal-title":"Int J Drug Policy"},{"key":"165_CR33","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/1747-597X-5-23","volume":"5","author":"B Tempalski","year":"2010","unstructured":"Tempalski B, Cleland CM, Pouget ER, Chatterjee S, Friedman SR. Persistence of low drug treatment coverage for injection drug users in large US metropolitan areas. Subst Abuse Treat Prev Policy. 2010;5:23.","journal-title":"Subst Abuse Treat Prev Policy"},{"key":"165_CR34","volume-title":"Subst Abus and Mental Health Services Administration, Office of Applied Studies: Treatment episode data set (TEDS) 1992\u20132008: [United States] [Computer file]","author":"Department of Health and Human Services","year":"2010","unstructured":"Department of Health and Human Services. Subst Abus and Mental Health Services Administration, Office of Applied Studies: Treatment episode data set (TEDS) 1992\u20132008: [United States] [Computer file]. Ann Arbor, MI: Synectics for. Management Decisions, Incorporated. Inter-university Consortium for Political and. Social Research; 2010."},{"key":"165_CR35","unstructured":"Department of Health and Human Services, Subst Abus and Mental Health Services Administration, Office of Applied Studies: Uniform Facility Data Set (UFDS) 1993\u20131995: [United States] [Computer file]. Ann Arbor, MI: Synectics for. Management Decisions, Incorporated. Inter-university Consortium for Political and. Social Research 1999."},{"key":"165_CR36","volume-title":"Substance abuse and mental health services administration, Office of Applied Studies: uniform facility data set (UFDS) 1997\u20131998: [United States] [computer file]","author":"Department of Health and Human Services","year":"2004","unstructured":"Department of Health and Human Services. Substance abuse and mental health services administration, Office of Applied Studies: uniform facility data set (UFDS) 1997\u20131998: [United States] [computer file]. 2nd ICPSR version ed. Ann Arbor, MI: Synectics for Management Decisions, Incorporated. Inter-university Consortium for Political and Soc Res; 2004.","edition":"2nd ICPSR versi"},{"key":"165_CR37","volume-title":"Substance Abuse and Mental Health Services Administration, Office of Applied Studies: National Survey of substance abuse treatment services (N-SSATS) 2000\u20132008: [United States] [computer file]","author":"Department of Health and Human Services","year":"2010","unstructured":"Department of Health and Human Services. Substance Abuse and Mental Health Services Administration, Office of Applied Studies: National Survey of substance abuse treatment services (N-SSATS) 2000\u20132008: [United States] [computer file]. 3rd ICPSR version ed. Ann Arbor, MI: Synectics for Management Decisions, Incorporated. Inter-university Consortium for Political and Soc Res; 2010.","edition":"3rd ICPSR versi"},{"key":"165_CR38","doi-asserted-by":"publisher","first-page":"e64789","DOI":"10.1371\/journal.pone.0064789","volume":"8","author":"B Tempalski","year":"2013","unstructured":"Tempalski B, Pouget ER, Cleland CM, Brady JE, Cooper HLF, Hall HI, Lansky A, West BS, Friedman SR. Trends in the population prevalence of people who inject drugs in US metropolitan areas 1992-2007. PLoS One. 2013;8:e64789.","journal-title":"PLoS One"},{"key":"165_CR39","first-page":"8228","volume":"65","author":"Office of Management and Budget","year":"2000","unstructured":"Office of Management and Budget. Standards for defining metropolitan and micropolitan statistical areas. Fed Register. 2000;65:8228\u201382238.","journal-title":"Fed Register"},{"key":"165_CR40","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/j.drugpo.2006.10.004","volume":"18","author":"SR Friedman","year":"2007","unstructured":"Friedman SR, Tempalski B, Brady J, Friedman JJ, Cooper H, Flom PL, McGrath MM, Gostnell K, Des Jarlais DC. Predictors of the degree of drug treatment coverage for injection drug users in 94 metropolitan areas in the United States. Int J Drug Policy. 2007;18:475\u201385.","journal-title":"Int J Drug Policy"},{"key":"165_CR41","volume-title":"HIV counseling and testing in publicly funded sites","author":"Centers for Disease Control and Prevention","year":"2010","unstructured":"Centers for Disease Control and Prevention. HIV counseling and testing in publicly funded sites. Atlanta, GA: Centers for Disease Control and Prevention; 2010."},{"key":"165_CR42","volume-title":"AIDS surveillance data","author":"Centers for Disease Control and Prevention","year":"2010","unstructured":"Centers for Disease Control and Prevention. AIDS surveillance data. Atlanta, GA: Centers for Disease Control and Prevention; 2010."},{"key":"165_CR43","doi-asserted-by":"publisher","first-page":"642","DOI":"10.2105\/AJPH.86.5.642","volume":"86","author":"S Holmberg","year":"1996","unstructured":"Holmberg S. The estimated prevalence and incidence of HIV in 96 large US metropolitan areas. Am J Public Health. 1996;86:642\u20135.","journal-title":"Am J Public Health"},{"key":"165_CR44","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1093\/jurban\/jth125","volume":"81","author":"SR Friedman","year":"2004","unstructured":"Friedman SR, Tempalski B, Cooper H, Perlis T, Keem M, Friedman R, Flom PL. Estimating numbers of injecting drug users in metropolitan areas for structural analyses of community vulnerability and for assessing relative degrees of service provision for injecting drug users. J Urban Health. 2004;81:377\u2013400.","journal-title":"J Urban Health"},{"key":"165_CR45","doi-asserted-by":"crossref","unstructured":"SAS Institute. SAS\/STAT\u00ae 9.3 User\u2019s guide. Cary, NC: SAS Institute; 2011.","DOI":"10.1002\/wics.131"},{"key":"165_CR46","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1080\/08897077.2015.1080208","volume":"37","author":"RM Burns","year":"2016","unstructured":"Burns RM, Pacula RL, Bauhoff S, Gordon AJ, Hendrikson H, Leslie DL, et al. Policies supporting opioid agonist therapy of opioid use disorders: the evolution of state policies from 2004 to 2013. Subst Abus. 2016;37:63\u20139.","journal-title":"Subst Abus"},{"key":"165_CR47","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s11920-017-0783-9","volume":"19","author":"A Sharma","year":"2017","unstructured":"Sharma A, Kelly SM, Mitchell SG, Gryczynski J, O'Grady KE, Schwartz RP. Update on barriers to pharmacotherapy for opioid use disorders. Curr Psychiatry Rep. 2017;19:35.","journal-title":"Curr Psychiatry Rep"},{"key":"165_CR48","unstructured":"European Monitoring Centre for Drugs and Drug Addiction Health and social responses to drug problems: a European guide, Publications Office of the European Union, Luxembourg, 2017."},{"key":"165_CR49","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1377\/hlthaff.2014.1205","volume":"34","author":"AW Dick","year":"2015","unstructured":"Dick AW, Pacula RL, Gordon AJ, et al. Increasing potential access to opioid agonist treatment in U.S Treatment Shortage Areas. Health affairs (Project Hope). 2015;34:1028\u201334.","journal-title":"Health affairs (Project Hope)"},{"key":"165_CR50","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1377\/hlthaff.2010.0532","volume":"30","author":"RE Clark","year":"2011","unstructured":"Clark RE, Samnaliev M, Baxter JD, Leung GY. The evidence doesn't justify steps by state Medicaid programs to restrict opioid addiction treatment with buprenorphine. Health Aff. 2011;30:1425\u201333.","journal-title":"Health Aff"}],"container-title":["Substance Abuse Treatment, Prevention, and Policy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13011-018-0165-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13011-018-0165-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13011-018-0165-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,28]],"date-time":"2022-08-28T23:54:21Z","timestamp":1661730861000},"score":1,"resource":{"primary":{"URL":"https:\/\/substanceabusepolicy.biomedcentral.com\/articles\/10.1186\/s13011-018-0165-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,9]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["165"],"URL":"https:\/\/doi.org\/10.1186\/s13011-018-0165-2","relation":{},"ISSN":["1747-597X"],"issn-type":[{"type":"electronic","value":"1747-597X"}],"subject":[],"published":{"date-parts":[[2018,8,9]]},"assertion":[{"value":"28 February 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 August 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare that they have no competing interests.Each author has contributed to the conception and design of the work, the acquisition of data or the analysis of the data in a manner substantial enough to take public responsibility for it. In addition, each author believes that the paper represents valid work and has reviewed the final version of the manuscript and approves consent for publication.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"28"}}